Centessa Pharmaceuticals Limited announced that Antoine Yver has been appointed Executive Vice President and Chairman of Development. In this newly created role reporting to the CEO, Dr. Yver will be accountable for the Company's overall development strategy, including scientific, clinical and regulatory matters, and will continue to provide support to research and clinical development teams. As a result of Dr. Yver taking on this elevated role, Javad Shahidi, MD, MSc, has joined the Company as Chief Medical Officer reporting to the CEO. Dr. Shahidi will oversee the clinical development teams and will be directly responsible for the overall design, delivery and management of clinical development, regulatory and medical affairs across Centessa.